Back to Search
Start Over
Targeting T cell plasticity in kidney and gut inflammation by pooled single-cell CRISPR screening.
- Source :
- Science Immunology; 2024, Vol. 9 Issue 96, p1-15, 15p
- Publication Year :
- 2024
-
Abstract
- Pro-inflammatory CD4<superscript>+</superscript> T cells are major drivers of autoimmune diseases, yet therapies modulating T cell phenotypes to promote an anti-inflammatory state are lacking. Here, we identify T helper 17 (T<subscript>H</subscript>17) cell plasticity in the kidneys of patients with antineutrophil cytoplasmic antibody–associated glomerulonephritis on the basis of single-cell (sc) T cell receptor analysis and scRNA velocity. To uncover molecules driving T cell polarization and plasticity, we established an in vivo pooled scCRISPR droplet sequencing (iCROP-seq) screen and applied it to mouse models of glomerulonephritis and colitis. CRISPR-based gene targeting in T<subscript>H</subscript>17 cells could be ranked according to the resulting transcriptional perturbations, and polarization biases into T helper 1 (T<subscript>H</subscript>1) and regulatory T cells could be quantified. Furthermore, we show that iCROP-seq can facilitate the identification of therapeutic targets by efficient functional stratification of genes and pathways in a disease- and tissue-specific manner. These findings uncover T<subscript>H</subscript>17 to T<subscript>H</subscript>1 cell plasticity in the human kidney in the context of renal autoimmunity. Editor's summary: Modulating plasticity in pathogenic T cells to promote a tolerogenic phenotype is a promising therapeutic approach in autoimmunity and cancer. To explore how pathogenic T<subscript>H</subscript>17 cell plasticity is regulated in mouse models of kidney and gut inflammation, Enk et al. optimized an in vivo pooled single-cell CRISPR droplet sequencing (iCROP-seq) screen. iCROP-seq enabled the assessment and quantification of CRISPR-modified T<subscript>H</subscript>17 cell polarization states in vivo. Furthermore, T cells from patients with antineutrophil cytoplasmic antibody (ANCA)–associated glomerulonephritis exhibited plasticity. These findings indicate that iCROP-seq can be applied to preclinical mouse models of inflammation and suggest that targeting T<subscript>H</subscript>17 plasticity in patients with ANCA-glomerulonephritis is a promising therapeutic approach. —Hannah Isles [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 24709468
- Volume :
- 9
- Issue :
- 96
- Database :
- Complementary Index
- Journal :
- Science Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 178301237
- Full Text :
- https://doi.org/10.1126/sciimmunol.add6774